Invesaro

Stocks Health care IXHL

NASDAQ · Health care

Incannex Healthcare Inc. (IXHL)

Incannex Healthcare Inc. reported revenue of $0 in fiscal 2026, down 100.0% from a year earlier. It posted a net loss of $19.3M. In fiscal 2026 capital spending exceeded operating cash flow by $12.9M. At June 30, 2026 it held $67.7M in cash. Its latest periodic report to the SEC is the annual report (10-K) filed on September 25, 2026.

Price
$3.32
-2.35% on the day · September 25, 2026
52-week range $2.49 to $19.71
Market cap
$39.7M
Revenue (FY2026)
$0
-100.0% year on year

What Incannex Healthcare Inc. does

Incannex Healthcare Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker IXHL.

Revenue and profit by year

Revenue
FY20: $604.9K $604.9K FY20FY22: $1.9M $1.9M FY22FY24: $12K $12K FY24FY25: $86K $86K FY25FY26: $0 $0 FY26
Net income
FY20: -$4.7M -$4.7M FY20FY22: -$11.4M -$11.4M FY22FY22: -$14.9M -$14.9M FY22FY23: -$48.8M -$48.8M FY23FY24: -$18.5M -$18.5M FY24FY25: -$46.9M -$46.9M FY25FY26: -$19.3M -$19.3M FY26

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2026$0-$23M-$19.3M-$1.66-$12.9M
2025$86K-$23.8M-$46.9M-$40.82-$12.5M
2024$12K-$30M-$18.5M-$34.77-$16.1M
2023n/a-$49.7M-$48.8M-$100.39-$11.1M
2022n/an/a-$14.9M-$96.53n/a
2022$1.9Mn/a-$11.4M-$89.58n/a

Latest SEC filings

What Incannex Healthcare Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 25, 2026
    Annual report 10-K · period to June 30, 2026
  2. September 9, 2026
  3. August 25, 2026
  4. August 14, 2026
  5. August 11, 2026
  6. July 23, 2026
  7. June 25, 2026
  8. June 10, 2026
  9. June 9, 2026
  10. May 15, 2026
    Quarterly report 10-Q · period to March 31, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on November 14, 2025. Insider transactions on SEC

All filings on SEC EDGAR

Questions about IXHL

What does Incannex Healthcare Inc. do?

Incannex Healthcare Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker IXHL.

Is Incannex Healthcare Inc. profitable?

No. In fiscal 2026 it reported a net loss of $19.3M.

How much revenue does Incannex Healthcare Inc. make?

In fiscal 2026 Incannex Healthcare Inc. reported revenue of $0. That is 100.0% less than a year earlier.

When did Incannex Healthcare Inc. last report?

Its most recent periodic report is the annual report (10-K) filed on September 25, 2026. It covers the period to June 30, 2026.

Similar companies

Follow IXHL

Get an email when Incannex Healthcare Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow IXHL: get an email when it files

Where the numbers come from

Financial figures are the values Incannex Healthcare Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.